Different methods for detecting patients with ALK-positive NSCLC are now available, such as immunohistochemistry (IHC), fluorescence in situ hybridization (FISH), and next-generation sequencing [14–16]. The gene discussed is ALK; the disease is non-small cell lung carcinoma.